The Drug Authority passes international accreditation requirements "Third level" In pharmaceutical preparations
The World Health Organization announced today that the Egyptian Pharmaceutical Authority has accredited the third level of maturity in regulatory authorities. This accreditation comes within the framework of the Egyptian government’s support to advance the pharmaceutical sector and enhance the ability of national institutions to obtain international accreditations, thus enhancing Egypt’s competitive position in The pharmaceutical industry at the global level.
The World Health Organization delegation expressed its appreciation for the developments and modernizations that the pharmaceutical sector in Egypt has witnessed recently, praising the efforts The exceptional and remarkable progress achieved in developing the drug control system thanks to the efforts of the Egyptian Medicine Authority.
The organization also emphasized the pivotal roles played by the Medicine Authority and state institutions in keeping pace with global developments. , which reflects Egypt’s commitment to applying the highest international regulatory standards, and that Egypt thus becomes the first African country to achieve third maturity in regulating both medicines and vaccines.
It included the organization’s announcement that passing the The Egyptian Medicines Authority meets the requirements of international accreditation, and its obtaining the third maturity level for pharmaceutical preparations is an achievement that reflects the efficiency of the Egyptian regulatory system and its ability to ensure the quality and safety of medical preparations in accordance with international standards.
The Authority It has made a number of unprecedented achievements in the region to achieve this accreditation in record time and with distinguished efforts that the organization has never witnessed before in the region.
These results confirm the confidence of the international community in the Egyptian drug control system, which It has proven its strength and integration at the regional and international levels.
For his part, Dr. Ali Al-Ghamrawi, Chairman of the Egyptian Medicines Authority, expressed his overwhelming happiness with this great achievement, and dedicated this historic achievement to President Abdel Fattah El-Sisi, and to the great people of Egypt, and expressed his thanks. To all the employees of the Egyptian Drug Authority who worked hard and sincerely and were loyal soldiers who demonstrated to the whole world the strength of the Egyptian drug regulatory system and its ability to develop and obtain the highest accreditations. International.
The Chairman of the Authority stressed that this accreditation will open the way for the flow of investments into the Egyptian pharmaceutical market, and enhance the reputation of Egyptian medicines and the high confidence in their quality and effectiveness, which will create a great demand for them, enhance export opportunities, and open the way for The flow of Egyptian medical products to all parts of the African continent, the Arab world, and the Middle East region.
He pointed out that the Egyptian Medicines Authority was able, in just four years, to obtain the two largest international accreditations from the World Health Organization in In the fields of vaccines and pharmaceutical preparations, the Egyptian Medicines Authority, with these accreditations, has become a global body on Egyptian soil, and a body with prestige and international standing in the field of regulation and control of pharmaceutical preparations and vaccines, and that it will assist sister African countries wishing to benefit from the Egyptian experience.
< p>For his part, Dr. Hetty Cielo, Head of the Regulatory and Safety Unit, Regulatory and Pre-Qualification Department, and Dr. Rogero Gasper, Director General of the Regulatory and Accreditation Department, congratulated Dr. Hanan Balkhi, WHO Regional Director for the Eastern Mediterranean, said: “This achievement reflects Egypt’s firm commitment to strengthening its health system to ensure access to safe and effective medical products.” By achieving WHO maturity level 3 for both vaccine and medicine regulation, Egypt has set a strong example for the region and beyond. This achievement underscores the critical role of strong regulatory systems in achieving universal health coverage and security. “.
Dr. Yukiko Nakatani, Assistant to the President-General of the World Health Organization for Access to Medicines and Health Products, said: “Achieving the third maturity level of the World Health Organization for drug regulation in… Egypt, along with a previous achievement of vaccine regulation, is a recognition of the country’s sustained investment in strengthening its health system and its commitment to ensuring that the highest standards of safety, effectiveness and quality are applied to medicines and other medical products. This dual recognition brings great value to the people of Egypt and sets a strong precedent. For regulatory excellence on the African continent, the World Health Organization is proud to support such progress, which emphasizes the vital role of strong regulatory systems in achieving universal health coverage and promoting global health equality.”
The Egyptian Medicines Authority continues its pioneering role in strengthening Egypt’s position. As a leading country in the field of drug control, which contributes to achieving sustainable development goals and providing safe, high-quality pharmaceutical products that meet the needs of local and international markets.
This comes within the framework of the authority’s keenness to Benefiting from global expertise and the experiences of relevant regulatory institutions, keeping pace with global developments and obtaining international accreditations in the field of vaccines and medicine.
